Product Information
CHLORDIAZEPOXIDE-CLIDINIUM CAP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.2545 per EA under NDC 62332074431. Its NADAC has been published 131 times since Feb 21, 2024.
FDA first approved this application on Sep 15, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 2.5 mg/1; mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332074431
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216969FDA Approved
9/15/2023
TE Code
AB
On Market Since
10/4/2023
Pharmacological Classes
Price Statistics
The NADAC for CHLORDIAZEPOXIDE-CLIDINIUM CAP has been published 131 times since Feb 21, 2024, and over the history we have for it it has declined 31.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2545 per EA |
|---|---|
| All-time high | $0.5272 (Oct 16, 2024) |
| All-time low | $0.2405 (Mar 18, 2026) |
| 52-week high | $0.3051 |
| 52-week low | $0.2405 |
| Median price | $0.2859 |
| Average price | $0.3061 |
| Largest weekly change | +78.0% (Aug 21, 2024) |
| Weeks tracked | 131 |
| Tracking since | Feb 21, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Chlordiazepoxide hydrochloride and clidinium bromide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CHLORDIAZEPOXIDE-CLIDINIUM CAP?
The current National Average Drug Acquisition Cost (NADAC) for CHLORDIAZEPOXIDE-CLIDINIUM CAP, manufactured by Alembic Pharmaceuticals Inc., is $0.2545 per EA (NDC 62332074431), effective Aug 19, 2026.
How has the price of CHLORDIAZEPOXIDE-CLIDINIUM CAP changed over time?
Over the history we have for it, the NADAC for CHLORDIAZEPOXIDE-CLIDINIUM CAP has declined 31.8%. It has been tracked across 131 weekly CMS publications since Feb 21, 2024.
What are the highest and lowest recorded NADAC prices for CHLORDIAZEPOXIDE-CLIDINIUM CAP?
Since Feb 21, 2024, the NADAC for CHLORDIAZEPOXIDE-CLIDINIUM CAP has ranged from a low of $0.2405 (Mar 18, 2026) to a high of $0.5272 (Oct 16, 2024), with a median of $0.2859 per EA.
Are there cheaper alternatives to CHLORDIAZEPOXIDE-CLIDINIUM CAP?
No other NADAC-published product currently shares the active ingredient and strength of CHLORDIAZEPOXIDE-CLIDINIUM CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CHLORDIAZEPOXIDE-CLIDINIUM CAP?
CHLORDIAZEPOXIDE-CLIDINIUM CAP (NDC 62332074431) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.